microRNA replacement therapy for mature B cell neoplasias

Project Information

HEAL-BY-MIRNA

Grant agreement ID: 713728

DOI 10.3030/713728

Project closed

EC signature date 25 April 2016

Start date 1 May 2016

End date 31 October 2017

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost € 149 750,00

EU contribution € 149 750,00

Coordinated by

CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)
Spain

Publications

Peer reviewed articles (1)

miR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma

Author(s): Nahikari Bartolomé-Izquierdo, Virginia G. de Yébenes, Angel F. Álvarez-Prado, Sonia M. Mur, Juan A. Lopez del Olmo, Sergio Roa, Jesus Vazquez and Almudena R. Ramiro
Published in: Blood, 2017, Page(s) 2408-2419, ISSN 0006-4971
Publisher: American Society of Hematology

Intellectual Property Rights

Patent (2)

MIRNAs AND COMBINATIONS THEREOF FOR USE IN THE TREATMENT OF HUMAN B CELL NEOPLASIAS

Application/Publication number: European Patent 17382740
Date: 2017-12-11

MiRNA compositions for the treatment of mature B-cell neoplasms

Application/Publication number: PCT EP2016/060927
Date: 2015-11-15